GABA-B Receptor Function in Healthy Volunteers

Status Completed

Clinical Trial Summary

There are several developing lines of evidence suggesting that brain receptors called GABA-B receptors play a significant role in addiction and its treatment. The investigators wish to examine the sensitivity of brain GABA-B receptors in alcohol and opiate addicts as part of the investigators MRC programme of research in neurotransmitters in alcohol and opiate addiction (NOAA). In this present study the investigators will give 2 different single doses of a drug called baclofen, and a placebo, to 8 healthy male volunteers. This drug affects GABA-B receptors in the central nervous system and is licensed for the treatment of spasticity in people with eg spinal injuries; the investigators are interested in its effects on brain GABA-B receptors. The investigators will measure EEG (brainwaves), eye movements, blood pressure and heart rate, motor co-ordination and subjective effects and also blood levels of the drug in the investigators volunteers before and at intervals after dosing. The investigators will use a double-blind randomised design to minimise expectation effects. The study will provide information on timing and magnitude of effects of baclofen on brain function in healthy subjects so that the investigators can optimise selection and timing of functional measures in future studies of addicts.

Clinical Trial Description

After informed consent and screening participants will attend for 3 study days. On each of these there will be a set of baseline measurements including EEG, saccadic eye movements, vital signs, motor co-ordination task, subjective visual analogue ratings and questionnaires and blood sample. After dosing these measurements will be repeated at intervals during the day up to 6 hours after dosing. Participants will be allowed home after a health check. ;

Study Design

Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01563224
Study type	Interventional
Source	Imperial College London
Contact
Status	Completed
Phase	N/A
Start date	July 2013
Completion date	September 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02265224` - Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)	Phase 1
Completed	`NCT00379210` - Neural Effects of Mindfulness Training on Attention	N/A
Completed	`NCT05901220` - Joint School-Health Project of the Neapolitan Child	N/A
Active, not recruiting	`NCT04455295` - Testing the Noradrenergic Hypothesis of Transcutaneous Vagus Nerve Stimulation	N/A
Not yet recruiting	`NCT03225638` - Performance Evaluation by Magnetic Resonance Imaging (MRI) of Intramuscular Thigh Injections With 3 Configurations of Needle-free Injector (ZENEO®)	N/A
Completed	`NCT04854642` - A Single Dose Study About the Influence of Food on the Oral Bioavailability of Ladarixin Capsule in Healthy Volunteers	Phase 1
Completed	`NCT04803396` - Ascending Dose Tolerability Trial and PK Assessment in Healthy Volunteers After Single & Multiple Oral Intake of DF2755A	Phase 1
Recruiting	`NCT03134482` - Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS	N/A
Recruiting	`NCT05882942` - Matcha Green Tea Effects at Rest and During Moderate-intensity Exercise in Females	N/A
Completed	`NCT03044301` - Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)	N/A
Terminated	`NCT04227405` - TOGETHER: A Couple's Model to Enhance Relationships and Economic Stability	N/A
Completed	`NCT04802967` - A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.